Accelerate to discover

Homepage>Discover>Use of the iQue Screener as a versatile tool for in-vitro immunogenicity and immunotoxicity risk assessment

Back to filter

Aug 20, 2020

Hyperpolarized 129Xe MR has been proven to be a powerful tool to evaluate the pulmonary function and has been widely...

Aug 11, 2020

2015 marked the first ever translation of hyperpolarized gas MRI to diagnostic clinical practice. Research at the...

Jul 29, 2020

Technology allowing evaluation of live animals repeatedly is indispensable to gain better insight into the dynamics of...

Jul 17, 2020

After a short introduction on the physio-pathological roles of platelets and the importance of their cell adhesion...

Sep 22, 2020

Jul 14, 2020

Watch the recorded webinar on PET/MR, driven by Peter Caravan at MGH for the application part, during which the launch...

Jul 1, 2020

Get answers to your questions on 3D spheroid-based drug discovery, organoid research and working with advanced cell...

Jun 22, 2020

The ability to monitore and quantitate lung disease in real time is an advantage to using small animal microCT. Also,...

Sep 22, 2020

Jun 1, 2020

Cancer genomics consortium members demonstrate 100% concordance between Bionano Genomics optical mapping technology and...

Use of the iQue Screener as a versatile tool for in-vitro immunogenicity and immunotoxicity risk assessment

Sep 29, 2015

Brecht Hoedemaekers, ImmunXperts

November 12th, 4pm BST

REGISTER NOW

Webinar

Get more info

Head of application support

Riccardo

Pasculli

+420 731 127 717

pasculli@accela.eu

Send Message

Brand profile

IntelliCyt Corporation's high throughput flow technology is the first to enable screening suspension cells, beads, microbes and mixtures.